Annual Accounts Payable
$41.67 M
+$24.39 M+141.04%
31 December 2023
Summary:
Travere Therapeutics annual accounts payable is currently $41.67 million, with the most recent change of +$24.39 million (+141.04%) on 31 December 2023. During the last 3 years, it has risen by +$29.54 million (+243.48%). TVTX annual accounts payable is now at all-time high.TVTX Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$23.20 M
-$2.65 M-10.25%
30 September 2024
Summary:
Travere Therapeutics quarterly accounts payable is currently $23.20 million, with the most recent change of -$2.65 million (-10.25%) on 30 September 2024. Over the past year, it has dropped by -$1.54 million (-6.23%). TVTX quarterly accounts payable is now -44.34% below its all-time high of $41.67 million, reached on 31 December 2023.TVTX Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TVTX Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +141.0% | -6.2% |
| 3 y3 years | +243.5% | +297.9% |
| 5 y5 years | +499.3% | +67.7% |
TVTX Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +243.5% | -44.3% | +297.9% |
| 5 y | 5 years | at high | +499.3% | -44.3% | +297.9% |
| alltime | all time | at high | >+9999.0% | -44.3% | >+9999.0% |
Travere Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $23.20 M(-10.2%) |
| June 2024 | - | $25.84 M(+54.5%) |
| Mar 2024 | - | $16.73 M(-59.9%) |
| Dec 2023 | $41.67 M(+141.0%) | $41.67 M(+68.5%) |
| Sept 2023 | - | $24.74 M(+24.2%) |
| June 2023 | - | $19.91 M(+19.1%) |
| Mar 2023 | - | $16.73 M(-3.3%) |
| Dec 2022 | $17.29 M(+14.2%) | $17.29 M(+23.4%) |
| Sept 2022 | - | $14.01 M(+18.2%) |
| June 2022 | - | $11.85 M(-35.7%) |
| Mar 2022 | - | $18.43 M(+21.7%) |
| Dec 2021 | $15.14 M(+24.8%) | $15.14 M(+159.8%) |
| Sept 2021 | - | $5.83 M(-30.1%) |
| June 2021 | - | $8.34 M(-44.4%) |
| Mar 2021 | - | $15.01 M(+23.7%) |
| Dec 2020 | $12.13 M(-54.4%) | $12.13 M(+28.7%) |
| Sept 2020 | - | $9.43 M(-7.5%) |
| June 2020 | - | $10.20 M(+2.3%) |
| Mar 2020 | - | $9.97 M(-62.6%) |
| Dec 2019 | $26.61 M(+282.7%) | $26.61 M(+92.4%) |
| Sept 2019 | - | $13.83 M(+10.5%) |
| June 2019 | - | $12.52 M(+64.1%) |
| Mar 2019 | - | $7.63 M(+9.7%) |
| Dec 2018 | $6.95 M(-63.3%) | $6.95 M(-25.3%) |
| Sept 2018 | - | $9.31 M(+18.7%) |
| June 2018 | - | $7.85 M(-16.7%) |
| Mar 2018 | - | $9.42 M(-50.2%) |
| Dec 2017 | $18.94 M | $18.94 M(+157.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2017 | - | $7.37 M(-18.8%) |
| June 2017 | - | $9.08 M(+94.3%) |
| Mar 2017 | - | $4.67 M(-37.9%) |
| Dec 2016 | $7.52 M(-1.5%) | $7.52 M(+145.3%) |
| Sept 2016 | - | $3.07 M(-51.2%) |
| June 2016 | - | $6.29 M(+35.2%) |
| Mar 2016 | - | $4.65 M(-39.2%) |
| Dec 2015 | $7.64 M(+7.2%) | $7.64 M(+56.1%) |
| Sept 2015 | - | $4.89 M(+2.4%) |
| June 2015 | - | $4.78 M(-19.2%) |
| Mar 2015 | - | $5.91 M(-17.0%) |
| Dec 2014 | $7.12 M(+100.5%) | $7.12 M(-36.9%) |
| Sept 2014 | - | $11.29 M(+6.2%) |
| June 2014 | - | $10.63 M(+86.0%) |
| Mar 2014 | - | $5.71 M(+60.7%) |
| Dec 2013 | $3.55 M(+247.3%) | $3.55 M(+106.4%) |
| Sept 2013 | - | $1.72 M(+20.7%) |
| June 2013 | - | $1.43 M(+194.1%) |
| Mar 2013 | - | $484.70 K(>+9900.0%) |
| Dec 2012 | $1.02 M(>+9900.0%) | - |
| Nov 2012 | - | $800.00(0.0%) |
| Aug 2012 | - | $800.00(0.0%) |
| May 2012 | - | $800.00(0.0%) |
| Feb 2012 | - | $800.00(0.0%) |
| Feb 2012 | $800.00(0.0%) | - |
| Nov 2011 | - | $800.00(0.0%) |
| Aug 2011 | - | $800.00(0.0%) |
| Feb 2011 | $800.00 | $800.00 |
FAQ
- What is Travere Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Travere Therapeutics?
- What is Travere Therapeutics annual accounts payable year-on-year change?
- What is Travere Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Travere Therapeutics?
- What is Travere Therapeutics quarterly accounts payable year-on-year change?
What is Travere Therapeutics annual accounts payable?
The current annual accounts payable of TVTX is $41.67 M
What is the all time high annual accounts payable for Travere Therapeutics?
Travere Therapeutics all-time high annual accounts payable is $41.67 M
What is Travere Therapeutics annual accounts payable year-on-year change?
Over the past year, TVTX annual accounts payable has changed by +$24.39 M (+141.04%)
What is Travere Therapeutics quarterly accounts payable?
The current quarterly accounts payable of TVTX is $23.20 M
What is the all time high quarterly accounts payable for Travere Therapeutics?
Travere Therapeutics all-time high quarterly accounts payable is $41.67 M
What is Travere Therapeutics quarterly accounts payable year-on-year change?
Over the past year, TVTX quarterly accounts payable has changed by -$1.54 M (-6.23%)